共 198 条
[51]
GARD S., 1951, ARCH GES VIRUSFORSCH, V4, P442, DOI 10.1007/BF01241164
[52]
GARD S, 1947, 4TH P INT C MICR COP
[53]
GEAR J, 1951, S Afr Med J, V25, P297
[54]
GEAR JHS, 1948, 4TH P INT C TROP MED, P555
[55]
GERSHOFF SN, 1952, P SOC EXP BIOL MED, V81, P484, DOI 10.3181/00379727-81-19917
[56]
Gey G, 1939, B JOHNS HOPKINS HOSP, V65, P393
[57]
COMPLEMENT-FIXING ANTIBODIES TO TYPE-2 (LANSING) POLIOMYELITIS VIRUS IN A NORMAL POPULATION OF A SUBTROPICAL AREA
[J].
JOURNAL OF EXPERIMENTAL MEDICINE,
1952, 96 (02)
:175-185
GOLDBLUM, N
;
MELNICK, JL
.
[58]
HABEL K, 1951, P SOC EXP BIOL MED, V76, P357, DOI 10.3181/00379727-76-18489
[59]
PRELIMINARY REPORT OF EPIDEMIOLOGICAL STUDIES ON POLIOMYELITIS AND STREPTOCOCCAL INFECTIONS - LANSING NEUTRALIZING ANTIBODY AND ANTISTREPTOLYSIN O SURVEYS OF CALIFORNIA CITIES, TEXAS, NORTH-CAROLINA, MEXICO, PACIFIC ISLANDS, AND JAPAN
[J].
AMERICAN JOURNAL OF PUBLIC HEALTH,
1950, 40 (03)
:293-306
HAMMON, WM
;
SATHER, GE
;
HOLLINGER, N
.
[60]
EVALUATION OF RED CROSS GAMMA-GLOBULIN AS A PROPHYLACTIC AGENT FOR POLIOMYELITIS .1. PLAN OF CONTROLLED FIELD TESTS AND RESULTS OF 1951 PILOT STUDY IN UTAH
[J].
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION,
1952, 150 (08)
:739-749
HAMMON, WM
;
CORIELL, LL
;
STOKES, J
.